RFP | July 15, 2009
New York State Department of Health, Empire State Stem Cell Board seeks a contractor to devise novel and improved derivation methods; increase efficiency in the production of new cell lines; standardize protocols to improve comparisons between human embryonic stem cells (hESC) and induced pluripotent stem cells; and enhance their potential for clinical application. There is a mandatory letter of intent due August 5, 2009 . . .